APVO
Aptevo Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.60
−1.23%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-437.1%
Return on equity
-181.9%
Return on assets
-262.3%
Return on invested capital
0.00x
Asset turnover
-$25.3M
Cash from operations
$5.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026